
A 16-amino-acid mitochondrial-derived peptide studied in research into metabolic homeostasis and AMPK-pathway signalling in experimental models.
HPLC ≥99% research peptides · Southampton since 2019 · next-day mainland
Catalogue
Incretin, mitochondrial and metabolic-pathway research chemicals for laboratory use — including retatrutide, semaglutide and MOTS-c listings.
37 compounds

A 16-amino-acid mitochondrial-derived peptide studied in research into metabolic homeostasis and AMPK-pathway signalling in experimental models.

A synthetic peptide fragment of the C-terminal region (residues 176–191) of human growth hormone, studied in research for lipolytic and metabolic-pathway activity in experimental models.

A synthetic lipidated peptide studied as a triple agonist of the GLP-1, GIP and glucagon receptors in experimental models.

A long-acting amylin-analogue peptide studied in metabolic and satiety-pathway receptor models. Research chemical only.

A lipidated GLP-1 receptor agonist peptide supplied strictly as a lyophilised laboratory reference compound — not a licensed medicine.

A dual GIP and GLP-1 receptor agonist peptide for laboratory receptor-binding and pathway work. Not a licensed medicine.

10 mg lyophilised retatrutide (triple GLP-1/GIP/glucagon agonist analogue) for laboratory research. Not a medicine.

5 mg lyophilised retatrutide reference peptide for smaller metabolic-pathway assays.

20 mg lyophilised retatrutide for metabolic-pathway laboratory work. Research chemical — not a licensed medicine.

15 mg lyophilised retatrutide (triple GLP-1/GIP/glucagon agonist analogue) for laboratory research. Not a medicine.

50 mg lyophilised retatrutide for laboratories that want a larger working aliquot. HPLC ≥99%. Research use only — not a pre-filled pen.

40 mg lyophilised retatrutide (same CAS as the 5 / 10 / 30 mg vials). Not a pre-filled pen and not a medicine.

60 mg lyophilised retatrutide for laboratories that want a larger working aliquot. HPLC ≥99%. Research use only.

A small-molecule NNMT-pathway research compound supplied as a lyophilised solid for metabolic laboratory models. Not a peptide, listed alongside the research catalogue for convenience.

An ERR-pathway research ligand for metabolic laboratory models. Defined chemical supply — not a medicine.

20 mg Semaglutide research vial. Laboratory reference — not Ozempic or Wegovy.

60 mg Tirzepatide research vial. Laboratory use only — not a licensed medicine.

2 mg Cagrilintide research vial for smaller metabolic-pathway assays.